VIDEOThis Labor Day Weekend, Talk to Every Woman You Know About Ovarian CancerBy Ruben RamirezSep 2, 2016 2:29 PM EDT
PRESS RELEASESAspira Women's Health, Inc. Announces First Patient Enrolled In Prospective OVANex Study For Benign Pelvic Mass MonitoringBy GlobeNewswireJun 29, 2020 8:00 AM EDT
PRESS RELEASESVermillion, Inc. Announces Rebranding And Company Name Change To Aspira Women's Health Inc.By GlobeNewswireJun 11, 2020 8:31 AM EDT
PRESS RELEASESVermillion Completes Validation Of New Pre-Surgical Test Offerings With OVA1®plus, Including COVID-19 Antibody Testing And Additional Pelvic Mass Risk Assessment BiomarkersBy GlobeNewswireJun 10, 2020 8:00 AM EDT
PRESS RELEASESVermillion Inc. Announces ASPiRA LABS Now Credentialed As Florida State Medicaid ProviderBy GlobeNewswireApr 14, 2020 8:00 AM EDT
PRESS RELEASESVermillion Announces Cigna Preferred Contract Coverage For OVA1, Overa And Genetics TestingBy GlobeNewswireMar 27, 2020 8:00 AM EDT
PRESS RELEASESGenomeSmartTM And ASPiRA LABS®, A Vermillion Company, Launch Pilot Program To Improve Access To Genetic TestingBy Business WireDec 3, 2019 1:00 AM EST
VIDEOThis Labor Day Weekend, Talk to Every Woman You Know About Ovarian CancerBy Ruben RamirezSep 2, 2016 2:29 PM EDT
STOCKSVermillion Management Discusses Q2 2012 Results - Earnings Call TranscriptBy Seeking AlphaAug 14, 2012 7:10 PM EDT
